• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

IVMA neutral on state fee for pharmaceutical firms

March 1, 2008
Krista Schultz

Kuna, Idaho - Estimates of how much revenue the state might receive from a proposed annual fee for veterinary pharmaceutical firms in Idaho could be inflated by as much as double, according to the Idaho Veterinary Medical Association (IVMA), which is taking a neutral stand on the measure.

Kuna, Idaho — Estimates of how much revenue the state might receive from a proposed annual fee for veterinary pharmaceutical firms in Idaho could be inflated by as much as double, according to the Idaho Veterinary Medical Association (IVMA), which is taking a neutral stand on the measure.

The bill is up for consideration a second time, after being killed last year amid strong opposition from the IVMA. It would charge manufacturers of animal and veterinary drugs $800 annually.

The IVMA is taking a neutral stance due to member ambivalence and moderate changes — particulary how the fee will be enacted — from last year's proposed bill, says Vicki Smith, IVMA executive director.

Estimated to bring in about $200,000 a year, the funds would go to the Idaho State Department of Agriculture's (ISDA) livestock disease control and tuberculosis indemnity account.

Advertisement

With the governor committed to provide matching funds, the bill will supplement the department's declining brand inspection revenues and offset rising service costs.

Resolution of last year's uncertainty over using a per-product versus per-company charge and less member opposition have led the IVMA to stand neutral, rather than opposed to the bill, Smith says.

Small-animal practioners are far removed from the ISDA, believed to be the reason behind an only 10 percent member response to an IVMA online poll to gauge members' reaction and interest. Out of more than 500 members, about 36 respondents opposed the bill, with 27 in favor.

Financial questions also linger with ISDA naming 302 statewide companies that will pay the annual fee, while an IVMA committee could only identify about 90, Smith says.

"That is part of the controversy. Will it raise the money they say? We are pretty doubtful," Smith says. "The whole crux is going to be how many of these companies there are."

There also is concern for DVMs who rely on smaller manufacturing companies for pharmaceuticals. "We are concerned there will be small companies out there that will disappear if they have to pay this fee," Smith says.

The fees also could impact pet owners at some point. "We are hoping this isn't going to reflect badly on client costs," she says.

The bill soon will be up for discussion in the state Senate. If it passes there, it would then go to the governor for final approval.

Related Content:

AssociationPolitics
Q&A with AVMA treasurer Dr Arnold L. Goldman
Q&A with AVMA treasurer Dr Arnold L. Goldman
FFAR and AAVMC are seeking applications for veterinary student research fellowships
FFAR and AAVMC are seeking applications for veterinary student research fellowships
AVMA announces Committee on Advancing Veterinary Technicians and Technologists
AVMA announces Committee on Advancing Veterinary Technicians and Technologists

Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement